PACB
Price
$1.09
Change
-$0.05 (-4.39%)
Updated
Apr 25 closing price
Capitalization
976.68M
12 days until earnings call
RVTY
Price
$94.29
Change
-$0.84 (-0.88%)
Updated
Apr 25 closing price
Capitalization
12.76B
2 days until earnings call
Ad is loading...

PACB vs RVTY

Header iconPACB vs RVTY Comparison
Open Charts PACB vs RVTYBanner chart's image
Pacific Biosciences of California
Price$1.09
Change-$0.05 (-4.39%)
Volume$9.76M
Capitalization976.68M
Revvity
Price$94.29
Change-$0.84 (-0.88%)
Volume$1.39M
Capitalization12.76B
PACB vs RVTY Comparison Chart
Loading...
PACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PACB vs. RVTY commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACB is a Hold and RVTY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (PACB: $1.09 vs. RVTY: $94.29)
Brand notoriety: PACB and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PACB: 103% vs. RVTY: 118%
Market capitalization -- PACB: $976.68M vs. RVTY: $12.76B
PACB [@Medical Specialties] is valued at $976.68M. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PACB’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).

  • PACB’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 0 green, 5 red.
According to our system of comparison, RVTY is a better buy in the long-term than PACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PACB’s TA Score shows that 2 TA indicator(s) are bullish while RVTY’s TA Score has 6 bullish TA indicator(s).

  • PACB’s TA Score: 2 bullish, 6 bearish.
  • RVTY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RVTY is a better buy in the short-term than PACB.

Price Growth

PACB (@Medical Specialties) experienced а -6.84% price change this week, while RVTY (@Medical Specialties) price change was +2.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.62%. For the same industry, the average monthly price growth was -3.92%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

PACB is expected to report earnings on Jul 30, 2025.

RVTY is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (+5.62% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than PACB($977M). RVTY YTD gains are higher at: -15.406 vs. PACB (-40.437). RVTY has higher annual earnings (EBITDA): 714M vs. PACB (-277.28M). RVTY has more cash in the bank: 1.6B vs. PACB (631M). PACB has less debt than RVTY: PACB (934M) vs RVTY (4.07B). RVTY has higher revenues than PACB: RVTY (2.75B) vs PACB (201M).
PACBRVTYPACB / RVTY
Capitalization977M12.8B8%
EBITDA-277.28M714M-39%
Gain YTD-40.437-15.406262%
P/E RatioN/A71.72-
Revenue201M2.75B7%
Total Cash631M1.6B39%
Total Debt934M4.07B23%
FUNDAMENTALS RATINGS
PACB vs RVTY: Fundamental Ratings
PACB
RVTY
OUTLOOK RATING
1..100
616
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
9585
PRICE GROWTH RATING
1..100
8663
P/E GROWTH RATING
1..100
7190
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (66) in the Medical Specialties industry is somewhat better than the same rating for PACB (100) in the Biotechnology industry. This means that RVTY’s stock grew somewhat faster than PACB’s over the last 12 months.

RVTY's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as PACB (100) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

RVTY's SMR Rating (85) in the Medical Specialties industry is in the same range as PACB (95) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

RVTY's Price Growth Rating (63) in the Medical Specialties industry is in the same range as PACB (86) in the Biotechnology industry. This means that RVTY’s stock grew similarly to PACB’s over the last 12 months.

PACB's P/E Growth Rating (71) in the Biotechnology industry is in the same range as RVTY (90) in the Medical Specialties industry. This means that PACB’s stock grew similarly to RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PACBRVTY
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 20 days ago
86%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 6 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Ad is loading...
PACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACUSX11.78N/A
N/A
Advisors Capital Total Return – Equity
AVUNX17.18N/A
N/A
Avantis® U.S. Equity G
LCCCX26.62N/A
N/A
Columbia Contrarian Core C
FBKFX15.22N/A
N/A
Fidelity Balanced K6
TOWFX15.98N/A
N/A
Towpath Focus Institutional

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with MASI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
-4.39%
MASI - PACB
58%
Loosely correlated
+0.68%
LAB - PACB
46%
Loosely correlated
-5.69%
AZTA - PACB
45%
Loosely correlated
-1.47%
RVTY - PACB
43%
Loosely correlated
-0.88%
BIO - PACB
42%
Loosely correlated
-2.85%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with IQV. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
-0.88%
IQV - RVTY
66%
Closely correlated
-0.27%
CRL - RVTY
63%
Loosely correlated
-0.95%
A - RVTY
62%
Loosely correlated
-0.69%
TMO - RVTY
62%
Loosely correlated
-0.57%
BIO - RVTY
60%
Loosely correlated
-2.85%
More